Crossmark

Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts

Crossref DOI link: https://doi.org/10.1080/2162402X.2025.2556714

Published Online: 2025-09-17

Published Print: 2025-12-31

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Polten, Robert

Kutle, Ivana

Stalp, Jan Lennart

Hachenberg, Jens

Seyda, Ann-Kathrin

Neubert, Lavinia https://orcid.org/0000-0003-4130-4185
Kamp, Jan C.

von Kaisenberg, Constantin

Schaudien, Dirk https://orcid.org/0000-0001-7398-7262
Hillemanns, Peter

Klapdor, Rüdiger

Morgan, Michael

Schambach, Axel
Funding

Funding for this research was provided by:

Bruno and Helene Jöster Foundation

Comprehensive Cancer Center Niedersachsen

REBIRTH Center for Translational Regenerative Medicine through the State of Lower Saxony (MWK: ZN3440)

Rudolf Bartling Foundation

Rudolf Bartling Stiftung

REBIRTH HANNOVER Forschungszentrum für translationale regenerative Medizin (MWK: ZN3440)
License Information

Version of Record valid from 2025-09-17
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=koni20

Publication History

Received: 2025-03-28

Revised: 2025-07-22

Accepted: 2025-08-31

Published: 2025-09-17